Ethnic specificity has become an integral part of research in the overlapping sciences of pharmacogenetics and pharmacogenomics. Pharmacogenomics in Admixed Populations was conceived to compile pharmacogenetic/-genomic (PGx) data from peoples of four continents: Africa, America, Asia and Oceania, where admixture and population stratification occurs in distinct patterns. The organization of this book was formed by a population PGx perspective: an initial review of the evolution of human genetic diversity leads into a series of chapters dealing with the population structure, and the PGx profiles, of various peoples selected on the basis of continents, countries or particular sub-groups within a continent or country.
Biography
Dr. G. Suarez-Kurtz, is Head of Pharmacology at the Brazilian National Cancer Institute— INCA— Coordinator of the Brazilian National Pharmacogenomics Network— REFARGEN— and a member of the Committee on Pharmacogenetics of the International Union of Pharmacology— IUPHAR. A pioneer of pharmacogenetic studies in the Brazilian population, his research explores the impact o f genetic admixture on the conceptual development and the praxis of pharmacogenetics/-genomics. He is a Full Member of the Brazilian Academy of Sciences, a Senior Investigator of the Brazilian National Research Council— CNPq— and a Professor of Clinical and Basic Pharmacology at Universidade do Brasil in Rio de Janeiro, where he received his M.D. and Ph.D. degrees. He did postgraduate work at Faculté de Médecine de Paris, Columbia University, New York and University College, London.
